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a b s t r a c t
Background: Enhanced intracellular Ca2+ signaling by stromal interactionmolecule 1 (STIM1)-
mediated store-operated Ca2+ entry (SOCE) is required for skeletal muscle differentiation.
However, the contribution of STIM2, STIM1’s analogue protein, onmuscle cell differentiation
has not been clearly elucidated. The present study aimed to explore the contribution of
STIM2-mediated SOCE on C2C12 myoblast differentiation.
Methods: Changes in STIM2 expression level (reverse transcription-polymerase chain reac-
tion and Western blotting) and SOCE activity ([Ca2+]i measurement) were measured during 3
days of in vitrodifferentiationofC2C12 skeletalmyoblast. Transcriptional regulationof STIM2
by nuclear factor of activated T cells, cytoplasmic (NFATc) overexpression was observed,
and the effect of STIM2 knockdown on NFAT transcriptional activity (luciferase assay) and
myoblast differentiation was quantiﬁed.
Results: Increase of STIM2 protein level and enhanced SOCE activity were observed in dif-
ferentiating myoblasts. Treatment with a SOCE blocker (2-APB) inhibited the differentiation.
Overexpression of NFATc1 increased STIM2 expression and SOCE activity. Knockdown of
STIM2 decreased NFAT transcriptional activity, SOCE activity, and differentiation of C2C12
myoblast.Conclusion: It is suggested that STIM2-activated SOCE controls C2C12 myoblast differentia-
tion.
© 2015 Korea Institute of Oriental Medicine. Published by Elsevier. This is an open access1. Introduction
Differentiation of skeletal myoblasts into multinucleated
myotubes is regulated by intracellular Ca2+ signaling.1,2 The
Ca2+ inﬂux pathway that raises intracellular [Ca2+]i include
2+ 2+voltage-gated Ca channels and store-operated Ca entry
(SOCE).2,3 SOCE involves Ca2+ entry channels that are acti-
vated by the depletion of sarcoplasmic reticulum (SR) Ca2+
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stores.4,5 Depletion of SR intraluminal Ca2+ is sensed by the SR
transmembrane protein called stromal interaction molecule
(STIM).4 The intraluminal facing Ca2+-binding domain of STIM
senses the depletion of stored Ca2+, and is then activated to
form homomultimeric complexes to make a clustered functa
at the SR plasma membrane (PM) juction.5 The cytoplasmicn University School of Medicine, Suwon 440-746, Korea.
domain of the clustered STIM proteins binds to a cytoplasmic
domain of the PM Ca2+-permeable cation channel (Orai Ca2+
channel), and this causes the Orai channel to open and allow
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he entry of Ca2+ (SOCE-mediated Ca2+ inﬂux).5 Many stud-
es have demonstrated that SOCE-mediated Ca2+ signaling is
equired for an efﬁcient muscle cell differentiation.3,6,7 In dif-
erentiated skeletal muscles, SOCE-mediated Ca2+ inﬂux was
nown to contribute to the maintenance of repeated muscle
ontraction, especially under the higher frequency of muscle
ontraction.6,7
Two isoformsof STIMproteins (STIM1andSTIM2) and three
soforms of Orai Ca2+ channels (Orai1, Orai2, and Orai3) have
eendiscovered.5 STIM1 andOrai1 are themost abundant pro-
eins that constitute SOCE in many different cells. Although
TIM2 is an analogue protein of STIM1, its functional roles
nd contributions on the whole SOCE-mediated Ca2+ signal-
ng are not clear. It has been proposed that STIM2 proteins
ossess a higher sensitivity to a decrease in intraluminal Ca2+
ontent; thus, it is easily activated by a partial depletion of
R Ca2+ stores.8–13 Therefore, it has been hypothesized that
TIM2 controls [Ca2+]i level in resting state or under a cir-
umstance with a mild agonist stimulation.10,11,13 Meanwhile,
TIM1 plays a signiﬁcant role when SR Ca2+ stores are inten-
ively depleted by strong agonist stimulation. It was suggested
hat crosstalk between STIM1 and STIM2 exists, and they have
ifferent potency for the activation of SOCE.11,12 Recently, it
as been suggested that STIM2 is activatedunder amild deple-
ion of Ca2+ stores at low agonist stimulation and promotes
ecruitment of STIM1 to the SR–PM junction.13 However, other
revious studies raised questions about this speciﬁc role of
TIM2. STIM2 has been suggested as an inhibitor of STIM1-
ediated SOCE.14 The intraluminal Ca2+ binding afﬁnity of the
terminusof STIM2doesnot seemtobe signiﬁcantly different
o that of STIM1.15
Our previous study on C2C12 myoblast differentiation
emonstrated that STIM1-activated SOCE is required for an
fﬁcient C2C12 myoblast differentiation.16 We have shown
hat STIM1 knockdown suppresses C2C12 differentiation and
TIM1 expression is positively regulated by the nuclear factor
f activated T cells cytoplasmic 3 (NFATc3) transcription fac-
or. The increased STIM1-mediated SOCE activity upon C2C12
ifferentiation stimulated Ca2+-dependent calcineurin/NFATc
ignaling and, in turn, it exertedpositive feedback to theSTIM1
rotein expression level.16 As a result, the decreased activity
f STIM1-mediated SOCE reduced NFAT-mediated transcrip-
ional activity and ﬁnally inhibited differentiation. However, it
s not clear whether STIM2 and STIM2-mediated SOCE activ-
ty controls C2C12 myoblast differentiation. Only a few studies
ave explored the roles of STIM2-regulated Ca2+ signaling in
keletal muscle differentiation and maturation.7 Therefore,
he aimof the present studywas to investigate the roles STIM2
n C2C12 myoblasts differentiation, mainly using a molecular
nockdown study.
. Methods
.1. C2C12 myoblast differentiation and myotube
uantiﬁcationhe experimental protocols on C2C12 myoblast culture and
ifferentiation have been described in previous studies.16,17
n brief, C2C12 myoblasts were cultured in DMEM (Dulbecco’s243
modiﬁed Eagle’s medium; Welgen Inc., Worcester, MA, USA)
growth medium supplemented with 15% fetal bovine serum,
1% penicillin, and streptomycin at 37 ◦C with 5% CO2. After
reaching > 90% conﬂuence, the growth medium was replaced
with differentiation medium (DM; DMEM supplemented with
2% horse serum) to differentiate myoblasts into myotubes for
the next 3 days. Differentiated myotubes were ﬁxed with 4%
cold paraformaldehyde (10minutes) and permeabilized with
cold methanol containing 0.3% H2O2 (10minutes). Next, 5%
horse serum was added to block the samples (30minutes).
The samples were incubated with anti-MyHC Ab at 4 ◦C
(overnight) and then incubated with biotylated antimouse Ab
(1:500, Jackson Immunoresearch,West Grove, PA, USA) at room
temperature (2hours). The samples were incubated with HRP-
conjugated streptoavidin (1:1000, Jackson Immunoresearch)
at room temperature (2hours), and then developed with
3,3′-diaminobenzidine chromogen (Dako, Glostrup, Denmark).
Myotube formation was quantiﬁed by counting the num-
ber of cells with mononucleus and multinucleated MyHC+
myotubes. Thepercentage of cellswithnucleusnumber of 1–2,
3–7, or ≥ 8MyHC+ myotubes is presented as a bar graph,where




Total RNA was extracted from C2C12 cells using the RNA
STAT-60 (Tell-Test, Inc., Friendswood, TX, USA) reagent,
following the instructions of the manufacturer; then, it
was reverse-transcribed into cDNA single strand using a
random hexamer primer SuperScript III RNase H-Reverse
Transcriptase (Invitrogen, Waltham, MA, USA). The fol-
lowing DNA sequences of the primers were used for
mouse STIM2 (363bp). Forward: 5′-TGAGGATACCCTGCAGTGG
-3′. Reverse: 5′-CAGTCTGCAGACTATCTAAG-3′. As a load-
ing control, GAPDH (300bp) with the following sequences
were used. Forward: 5′-TGTCTTCACCATGGAG-3′. Reverse: 5′-
CGGCCATCACGCCACAGCTT-3′.
2.3. Western blotting and antibodies
For cell protein extraction, the same protocols used in our pre-
vious study were followed.16 Total cell lysates were resolved
by sodium dodecyl sulfate-polyacrylamide gel electrophore-
sis (6–10%) and transferred to a polymer of vinylidene ﬂuoride
(PVDF) membranes, and then incubated in a blocking solu-
tion (5% skim milk in Tris-buffered saline and 0.1% Tween
20) for 1 hour at room temperature. Immunoblotting was per-
formed with the following antibodies (Ab): anti-STIM2 and
anti-NFATc1 Ab, which were obtained from ProSci Company
(Fort Collins, CO, USA); anti--actin Ab, which was purchased
from Sigma (St. Louis, MO, USA); and anti-MyHCAb, which was
obtained from Santa Cruz Biotechnology (Dallas, TX, USA).
Unless otherwise stated, all chemicals used in this study were
purchased from Sigma.2.4. Stable knockdown of STIM2
To construct C2C12 cells with stable knockdown of STIM2,
the shRNA target sequence for mouse STIM2 (accession
244
number: NM 001081103.2) was selected using the Invitrogen
shRNA design tool. The following DNA sequences of shSTIM2
were used. Forward: 5′-gatccc GGCCAGACACAGCTTCAGAA
ttcaagaga TTCTGAAGCTGTGTCTGGC ttttttggaaa-3′. Reverse:
5′-agcttttccaaaaaaGCCAGACACAGCTTCAGAA tctcttgaa TTCT-
GAAGCTGTGTCTGGCC gg-3′. Oligonucleotides were cloned
into p-Super.puro vector (Clontech, Mountain View, CA,
USA). C2C12 myoblasts were transfected with shSTIM2 or
p-Super.puro vector using lipofectamineTM2000 (Invitrogen)
for 48hours, and then puromycin (1g/mL)-resistant colonies
were selected for a week. STIM2 knockdown (STIM2-KD) was
conﬁrmed with Western blot analysis.
2.5. Overexpression of NFATc
Each NFATc isoform (NFATc1, c2, c3, and c4) was transiently
transfected into C2C12 cells by lipofectaminTM2000 (1.5g
cDNA, 48hours). The NFATc cDNA sources and validation
method for NFATc overexpression were described in our
previous study.9 After overexpressing the cells with NFATc
isoforms, the changes in STIM2 expression level was con-
ﬁrmed with reverse transcription-polymerase chain reaction
and Western blotting against STIM2.
2.6. Luciferase assay
Luciferase assaywasperformed to estimate the effect of STIM2
silencing on NFAT transcriptional activity. Luciferase reporter
plasmids NFAT-Luc, a ﬁreﬂy luciferase reporter with a deﬁned
promoter, and renilla luciferase control plasmid were cotrans-
fected into control or STIM2 knockdown C2C12 myoblasts
(48hours). Harvested myoblasts were lysed, and NFAT-Luc
and renilla luciferase activities were assayed with the dual
luciferase assay kit (Promega, Madison, WI, USA).
2.7. Measurement of [Ca2+]i and SOCE activity
SOCE-mediated Ca2+ inﬂux was measured in C2C12 myoblasts
or differentiated myotubes with Ca2+ ﬂuorescent dye fura-
2 (3M; Molecular Probes, Waltham, MA, USA), as we have
previously described.16 Fura-2-loaded cells were bathed in
normal Tyrode solution contained (in mM) 145 NaCl, 5 KCl, 2
CaCl2, 1.5MgCl2, 10 glucose, and 20HEPES [4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid; pH 7.4], and placed in a
1-mL temperature-controlled cuvette system (DeltaScan, PTI,
Birmingham, NJ, USA). Fura-2 ﬂuorescence ratios (F340/F380)
were recorded and calculated into the [Ca2+]i by the treat-
ment of Ca2+ ionomycin (Biomol, Hamburg, Germany) and
ethylene glycol tetraacetic acid (EGTA) at the end of each
measurement.18 To measure SOCE activity, cells were treated
with an SR Ca2+-ATPase inhibitor thapsigargin (Tg, 1M) to
deplete SR Ca2+ stores in Ca2+-free bathing solution (nominal
Ca2+-free with 2.5mM EGTA-containing Tyrode solution). To
magnify the magnitudes of SOCE-mediated Ca2+ entry, 7.5mM
Ca2+ was reintroduced to the bath solution after depleting SR
stores with Tg.2.8. Statistical analysis
Data are presented as mean± standard error of the mean with
n, the sample numbers of experiments. Statistical signiﬁcanceIntegr Med Res ( 2 0 1 5 ) 242–248
was assessed using the unpaired Student t test, and p <0.05
was considered statistically signiﬁcant.
3. Results
3.1. Increased expression of STIM2 during C2C12
differentiation
Both mRNA and protein expression level of STIM2 were gradu-
ally increased during the 3-day differentiation period (Fig. 1A).
As the STIM2 expression level increased, the functional activ-
ity of SOCE was increased in the differentiated myotubes
at 3 days of differentiation (DM3; Fig. 1B, left panel). The
activated SOCE was efﬁciently inhibited by treatment with 2-
APB (50M), a commonly used SOCE blocker. In addition, the
differentiated myotubes at DM3 showed an increased rest-
ing [Ca2+]i level and a higher SR Ca2+ content (Fig. 1B, right
panel). The contribution of SOCE-mediated Ca2+ signaling on
C2C12myotube formationwas tested by treating the cellswith
2-APB. Treatment with 2-APB (25–50M) during the 3-day dif-
ferentiation periodmarkedly inhibited themyotube formation
(Fig. 1C), suggesting that SOCE activity is required for efﬁcient
differentiation.
3.2. NFATc regulation of STIM2 and SOCE
The STIM2 mRNA levels were increased by about 2-fold via
overexpression of NFATc isoforms (NFATc1, c2, c3, and c4) in
C2C12 myoblasts (p < 0.01; Fig. 2A). The degree of increase
in STIM2 mRNA by NFATc was not different among isoforms.
We overexpressed one of these NFTAc isoforms, NFATc1, into
C2C12 myoblasts and measured the change in STIM2 protein
level. NFATc1 overexpression resulted in an increase of the
STIM2 protein level and a higher SOCE activity (Figs 2B, 2C).We
tested whether NFATc and STIM2 have a reciprocal regulation
mechanism, as the positive feedback relationship between
NFATc3 and STIM1.16 As shown in Fig. 2D, basal NFAT tran-
scriptional activity decreased to ∼50% in STIM2-KD cells.
Altogether, the results suggest that NFATc positively regulates
STIM2protein expression and STIM2-mediated SOCE, and vice
versa.
3.3. STIM2-KD decreases SOCE activity and myoblast
differentiation
To evaluate the functional consequences of STIM2 silencing
on SOCE activity and the muscle differentiation, we generated
stable STIM2-KD C2C12 myoblasts, and they were induced
to differentiate. In differentiated STIM2-KD myotubes, SOCE
amplitudes were reduced to 61.5±1.6% of control (p < 0.01;
Figs. 3A, 3B). In addition, resting [Ca2+]i levels and the amounts
of SRCa2+ release by Tgwere reduced to 78±2.9% (p<0.05) and
80.1±9.5% of control (p<0.05), respectively (Fig. 3B). Myoblast
differentiation was reduced in STIM2-KD cells, which is char-
acterized by the formation of relatively narrower myotubes
(Fig. 3C). The percentage of MyHC+ myotubes with ≥ 8
nuclei was signiﬁcantly reduced to 61.85±16.8% of control
(p<0.05; Fig. 3D). When STIM2-KD myoblasts were differ-
entiated into myotubes, lowered STIM2 protein levels were
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Fig. 1 – Increased expression of STIM2 and SOCE activity during C2C12 myoblast differentiation. (A) Changes in mRNA (left
panel) and protein expression (right panel) of STIM2 during 3 days of myoblast differentiation were quantiﬁed by RT-PCR
and Western blotting, respectively. (B) Increasing SOCE activities were compared between the C2C12 cells at differentiation
Day 1 (DM1) and Day 3 (DM3). Myotubes at DM3 showed much higher SOCE-mediated Ca2+ inﬂux that is blocked by 50M
2-APB. Magnitude of SOCE recorded at DM1 was similar to the proliferating myoblast (data not shown). Higher resting [Ca2+]i
and SR Ca2+ contents are shown in the myotubes at DM3. The SR Ca2+ stores were depleted by 1M thapsigargin in
Ca2+-free bathing solution, and a higher extracellular Ca2+ (7.5mM) was added back to the bath solution to magnify SOCE
activities. *p<0.05, #p < 0.01; n=4. (C) C2C12 myoblasts were differentiated for 3 days within the culture medium that
contained a SOCE blocker 2-APB (25M or 50M), and the degree of myotube formation was analyzed with MyHC+
immunohistochemistry at DM3. Scale bars=100m.


















tarcoplasmic reticulum; STIM2, stromal interaction molecul
aintained during 3 days of differentiation (Fig. 3E). These
esults demonstrated that STIM2 silencing impairs SOCE
ctivity and consequent C2C12 myoblast differentiation.
. Discussion
he present study demonstrated that STIM2 can regulate
he efﬁciency of C2C12 myoblast differentiation. As C2C12
yoblasts differentiate into multinucleated myotubes, an
ncreased STIM2 expression (mRNA and protein) was accom-
anied with an increased SOCE activity (Fig. 1). This kind of
xpression pattern of STIM2 and SOCE looks almost iden-
ical to that of STIM1-mediated response in differentiating
2C12 cells.16 The inhibitory effect of 2-APB on SOCE and
yoblast differentiation (Figs. 1B, 1C) indirectly indicated themportant roles of SOCE-mediated Ca2+ signaling in myoblast
ifferentiation. Because no pharmacological selectivity of
-APB on STIM1- or STIM2-mediated SOCE was described,
he data presented in Fig. 1 merely indicate the importanceof SOCE-mediated Ca2+ signaling in C2C12 differentiation.
To prove the relevance of STIM2 on muscle differentiation,
we constructed STIM2-KD stable cells and then analyzed
the functional consequences of STIM2 silencing on cellular
[Ca2+]i, SOCE activity, NFAT transcriptional activity, and the
myoblast differentiation (Fig. 3). Our knockdown data showed
that STIM2-KD impaired C2C12 myoblast differentiation with
a lower percentage of multinucleated myotubes. A reduced
SOCE activity recorded in STIM2-KD myotubes (Fig. 3A)
corresponded well to the lowered STIM2 protein expression
(Figs. 3A, 3C). A lower level of resting [Ca2+]i was observed in
STIM2-KD myotubes (Fig. 3B), which is in line with previous
studies suggesting that STIM2 is an important regulator for
maintaining the resting [Ca2+]i level. Our present results are in
accordance with those of a previous study on human skeletal
muscle differentiation, in which both STIM1 and STIM2
proteins are required for human myoblast differentiation and
myotube excitation–contraction coupling.6,7
Although we observed impaired C2C12 differentiation by
knockdown of STIM2, the degree of impairment is relatively
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Fig. 2 – NFATc regulates the expression levels of STIM2 and SOCE activity of C2C12 myoblast. (A) The increased STIM2
mRNA levels were quantiﬁed by qRT-PCR in C2C12 myoblasts with overexpression of individual NFATc isoforms. Shown are
means±SD from two independent experiments (n=4–6, #p<0.01). (B) The increased STIM2 protein level by the transfection
of NFATc1 was quantiﬁed by Western blotting in C2C12 myoblasts. (C) Representative [Ca2+]i measurement that shows an
increase in SOCE activity in NFATc1-overexpressed myoblasts is plotted. (D) Decreased NFAT transcriptional activity in
STIM2-KD myoblasts was measured by luciferase assay (3 independent experiments, n=6, #p<0.01).
KD, knockdown; NFATc, nuclear factor of activated T cells, cytoplasmic; qRT-PCR, quantitative reverse
transcription-polymerase chain reaction; SD, standard deviation; SOCE, store-operated Ca2+ entry; STIM2, stromal
interaction molecule 2.weaker than that of STIM1-KD C2C12 cells, as shown in our
previous experiment.16 Therefore, it may be suggested that
STIM1 is more important than STIM2 for differentiation of
myotubes in vitro, at least in the murine C2C12 myoblast cell
line. A major limitation of the present study with STIM2-
KD is that we did not track the changes in the expression
of STIM1 and its counterpart protein Orai1 from the differ-
entiating STIM2-KD cells. If the amount of functional STIM1
protein is enough to compensate for the lack of STIM2, only a
mild phenotypic change in SOCE-mediated Ca2+ signal and
muscle differentiation could be expected. In other sets of
experiments, we have observed that a reciprocal compensat-
ing interaction mechanism exists between STIM1 and STIM2
expression in C2C12 myoblasts (data not shown). In partic-
ular, a noticeable compensatory increase of STIM2 protein
has been observed from STIM1 ablated cells. On the con-
trary, there was only a minor compensatory increase in the
STIM1 protein level in STIM2 ablated cells (data not shown).
Given that STIM1 is a major player of SOCE-controlled C2C12
differentiation,3,16 STIM2 can be regarded as a supportive
molecule to the STIM/SOCE-mediated signaling. However, this
interpretation should be inspected carefully by in-depth stud-
ies, such as STIM-double knockout studies.It has been well understood that intracellular Ca2+-
calcineurin-NFAT signaling cascade is a key player for the
control of myoblast differentiation.19–21 In the present study,STIM2 mRNA levels were upregulated ∼2-fold by transfected
NFATc isoforms (NFATc1–c4) with no preference on a speciﬁc
NFATc isoform (Fig. 2A). Transfected NFATc1 increased not
only the amounts of STIM2 protein but also SOCE activity,
suggesting that NFATc1 upregulates STIM2-activated SOCE
(Figs. 2B, 2C). However, the present work did not test whether
other NFATc isoforms, i.e., NFATc2–c4, can increase STIM2
protein level. Our previous study with C2C12 cells showed
that the expression level of STIM1 (mRNA and protein) is
exclusively upregulated by the NFATc3 isoform.16 In addition,
the study demonstrated that a reciprocal positive feedback
mechanism exists between NFATc3 and STIM1. In comparison
with an exclusive control of STIM1 by NFTAc3,16,21 our study
may suggest that the transcriptional regulation of STIM2
by NFATc has no preference for a speciﬁc NFATc isoform,
even if the signaling strength that comes from each isoform
might be different. The fact that STIM2 silencing decreased
NFATc transcriptional activity (Fig. 2D) suggests that STIM2
activation of SOCE is coupled to the Ca2+-dependent NFAT
transcriptional activation of STIM2 expression. It means,
therefore, that a positive feedback loop exists between NFATc
and STIM2 in the course of myoblast differentiation pro-
cesses, similar to the crosstalk between NFATc3 and STIM1.16Taking into account that the activity of calcineurin-mediated
transactivation of NFATc is dependent on the magnitude of
intracellular [Ca2+]i,20,21 the overall Ca2+-dependent control
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Fig. 3 – Knockdown (KD) of STIM2 reduces SOCE activity and impairs C2C12 myoblast differentiation. (A) Representative
traces of [Ca2+]i measured at differentiation Day 3 (DM3) from control or STIM2-KD (siSTIM2) myotubes. (B) Summary bar
graphs represent the changes in resting [Ca2+]i, SR Ca2+ release, SOCE activity, and 2-APB-sensitive SOCE component by
knockdown of STIM2 (n=3; *p<0.05, #p<0.01). (C) Representative images of MyHC+ cells taken from control and STIM2-KD
myotubes at DM3. Shown are representative images from three independent experiments. Scale bars=100m. (D)
Quantiﬁcation of nuclei number in MyHC+ cells at DM3. The percentage of MyHC+ myotubes with eight or more nuclei was
61.85±16.8% of control (n=3, *p<0.05). (E) The decreased STIM2 protein expression level was maintained during 3 days of
















rD, knockdown; SOCE, store-operated Ca2+ entry; SR, sarcop
f the skeletal muscle differentiation can be signiﬁcantly
egulated by the expression regulation of STIM proteins or
FATc isoforms, in terms of protein levels.
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